A strain-independent postnatal neurodegeneration in mice lacking the EGF receptor.

gan Sibilia, M, Steinbach, J P, Stingl, L, Aguzzi, A, Wagner, E F
Cyhoeddwyd 1998

Lower Lactate Levels and Lower Intracellular pH in Patients with IDH-Mutant versus Wild-Type Gliomas

gan Wenger, K.J., Steinbach, J.P., Bähr, O., Pilatus, U., Hattingen, E.
Cyhoeddwyd yn AJNR Am J Neuroradiol (2020)

P10.04 Anti-angiogenetic Therapy with Bevacizumab for Gliomas with a Gliomatosis Cerebri Growth Pattern

gan Burger, M. C., Mildenberger, I. C., Wagner, M., Mittelbronn, M., Steinbach, J. P.
Cyhoeddwyd yn Neuro Oncol (2017)

P01.10 METABOLIC CONDITIONS DETERMINE SENSITIVITY OF GLIOMA CELLS AGAINST EPIDERMAL-GROWTH FACTOR RECEPTOR (EGFR)-INHIBITION

gan Hartel, I.A., Wolking, S., Wanka, C., Ronellenfitsch, M.W., Steinbach, J.P., Rieger, J.
Cyhoeddwyd 2014

P01.11 The transcriptional coactivator PGC-1a promotes defence against reactive oxygen species (ROS) and proliferation in human glioma cells

gan Hartel, I., Sauer, B., Burger, M., Ronellenfitsch, M. W., Steinbach, J. P., Rieger, J.
Cyhoeddwyd yn Neuro Oncol (2016)

P06.05 Myoinositol as a predictive baseline biomarker for overall survival of patients with recurrent glioblastoma treated with Bevacizumab: A 1H-magnetic resonance spectroscopy st...

gan Steidl, E., Pilatus, U., Steinbach, J. P., Zanella, F., Ronellenfitsch, M. W., Hattingen, E., Bähr, O.
Cyhoeddwyd yn Neuro Oncol (2016)

OS1.4 Current treatment regimens induce the mTORC1 inhibitor REDD1 in human glioblastoma cells: implications for treatment efficacy

gan Foltyn, M., Thiepold, A., Harter, P. N., Baumgarten, P., Mittelbronn, M., Urban, H., Steinbach, J. P., Ronellenfitsch, M. W.
Cyhoeddwyd yn Neuro Oncol (2016)

P04.24 MTOR signaling in glioma-associated microglia and macrophages

gan Zeiner, P S, Lorenz, N I, Burger, M, Luger, A L, Harter, P N, Steinbach, J P, Ronellenfitsch, M W
Cyhoeddwyd yn Neuro Oncol (2018)

P04.21 Combination therapy of CAR-NK cells and anti-PD-1 antibody displays potent efficacy against late-stage Glioblastoma and induces protective antitumor immunity

gan Strassheimer, F, Zhang, C, Mildenberger, I C, Harter, P N, Tonn, T, Steinbach, J P, Wels, W S, Burger, M C
Cyhoeddwyd yn Neuro Oncol (2018)

P04.47 Nrf2 mediates hypoxic tolerance in human glioblastoma cells

gan Lorenz, N I, Luger, A, Zeiner, P S, Engel, A L, Harter, P N, Steinbach, J P, Ronellenfitsch, M W
Cyhoeddwyd yn Neuro Oncol (2018)

O6.05 ERBB2/HER2-SPECIFIC NATURAL KILLER CELLS FOR ADOPTIVE IMMUNOTHERAPY OF GLIOBLASTOMA

gan Burger, M.C., Zhang, C., Jennewein, L., Schönfeld, K., Genßler, S., Grez, M., Tonn, T., Mittelbronn, M., Steinbach, J.P., Wels, W.S.
Cyhoeddwyd 2014

P16.11 Complete resection is not associated with improved survival in MGMT non-methylated glioblastoma. Results from the GLARIUS trial

gan Kebir, S., Stummer, W., Steinbach, J. P., Weyerbrock, A., Hau, P., Goldbrunner, R., Proescholdt, M., Vatter, H., Herrlinger, U., Glas, M.
Cyhoeddwyd yn Neuro Oncol (2017)

P01.03 mTORC1 activation sensitizes human malignant glioma cells to hypoxia-induced cell death by increasing O2-consumption

gan Thiepold, A. L., Foltyn, M., Urban, H., Heller, S., Dröse, S., Harter, P. N., Mittelbronn, M., Steinbach, J. P., Ronellenfitsch, M. W.
Cyhoeddwyd yn Neuro Oncol (2016)

P01.101 Treatment and survival of patients with lower grade glioma according to the 2007 and the 2016 WHO classification: A retrospective analysis of 423 patients.

gan Steidl, E, Zeiner, P, Wagner, M, Fokas, E, Forster, M, Ronellenfitsch, M, Steinbach, J P, Harter, P N, Bähr, O
Cyhoeddwyd yn Neuro Oncol (2018)

O10.04 THE RANDOMIZED, MULTICENTER GLARIUS TRIAL INVESTIGATING BEVACIZUMAB/IRINOTECAN VS STANDARD TEMOZOLOMIDE IN NEWLY DIAGNOSED, MGMT-NON-METHYLATED GLIOBLASTOMA PATIENTS: FINAL...

gan Herrlinger, U., Schäfer, N., Steinbach, J.P., Weyerbrock, A., Hau, P., Goldbrunner, R., Leutgeb, B., Urbach, H., Stummer, W., Glas, M.
Cyhoeddwyd 2014

P04.05 The CAR2BRAIN study: a monocentric phase I trial with ErbB2-specific NK-92/5.28.z cells in recurrent glioblastoma

gan Burger, M. C., Mildenberger, I., Zhang, C., Ihrig, K., Wagner, M., Mittelbronn, M., Senft, C., Tonn, T., Wels, W. S., Steinbach, J. P.
Cyhoeddwyd yn Neuro Oncol (2016)

P01.31 Mammalian target of rapamycin complex 1 activation sensitizes human glioma cells to hypoxia-induced cell death

gan Thiepold, A., Foltyn, M., Urban, H., Voss, M., Hofmann, U., Dröse, S., Harter, P. N., Mittelbronn, M., Steinbach, J. P., Ronellenfitsch, M. W.
Cyhoeddwyd yn Neuro Oncol (2017)

P12.04 Synergistic effects of combination therapy of CAR-NK cells and anti-PD-1 antibody result in high efficacy against advanced stage orthotopic glioblastoma grafts in a syngenei...

gan Strassheimer, F, Strecker, M I, Zhang, C, Mildenberger, I C, Harter, P N, Tonn, T, Steinbach, J P, Wels, W S, Burger, M C
Cyhoeddwyd yn Neuro Oncol (2019)

P04.50 Doxycycline impairs mitochondrial function and protects human glioma cells from hypoxia-induced cell death: implications of using Tet-inducible systems

gan Sauer, B, Luger, A, Lorenz, N I, Engel, A L, Braun, Y, Voss, M, Harter, P N, Steinbach, J P, Ronellenfitsch, M W
Cyhoeddwyd yn Neuro Oncol (2018)

P14.96 Gliomatosis cerebri imaging pattern: a treatment-independent marker for worse overall survival in WHO grade II and III gliomas

gan Divé, I, Steidl, E, Wagner, M, Burger, M C, Franz, K, Harter, P N, Bähr, O, Fokas, E, Herrlinger, U, Steinbach, J P
Cyhoeddwyd yn Neuro Oncol (2019)